Neurofibroma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Sara Mohsin (talk | contribs) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neurofibroma}} | {{Neurofibroma}} | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}}{{S.M.}} {{SC}} | ||
==Overview== | ==Overview== | ||
There are no secondary preventive measures available for neurofibroma. | There are no [[Secondary prevention|secondary preventive measures]] available for [[neurofibroma]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no secondary preventive measures available for neurofibroma. | There are no [[Secondary prevention|secondary preventive measures]] available for [[neurofibroma]]. | ||
==References== | ==References== |
Latest revision as of 01:15, 29 April 2019
Neurofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neurofibroma secondary prevention On the Web |
American Roentgen Ray Society Images of Neurofibroma secondary prevention |
Risk calculators and risk factors for Neurofibroma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Shanshan Cen, M.D. [3]
Overview
There are no secondary preventive measures available for neurofibroma.
Secondary Prevention
There are no secondary preventive measures available for neurofibroma.